Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium

Autor: Grivas, P, Khaki, AR, Wise-Draper, TM, French, B, Hennessy, C, Hsu, C-Y, Shyr, Y, Li, X, Choueiri, TK, Painter, CA, Peters, S, Rini, BI, Thompson, MA, Mishra, S, Rivera, DR, Acoba, JD, Abidi, MZ, Bakouny, Z, Bashir, B, Bekaii-Saab, T, Berg, S, Bernicker, EH, Bilen, MA, Bindal, P, Bishnoi, R, Bouganim, N, Bowles, DW, Cabal, A, Caimi, PF, Chism, DD, Crowell, J, Curran, C, Desai, A, Dixon, B, Doroshow, DB, Durbin, EB, Elkrief, A, Farmakiotis, D, Fazio, A, Fecher, LA, Flora, DB, Friese, CR, Fu, J, Gadgeel, SM, Galsky, MD, Gill, DM, Glover, MJ, Goyal, S, Grover, P, Gulati, S, Gupta, S, Halabi, S, Halfdanarson, TR, Halmos, B, Hausrath, DJ, Hawley, JE, Hsu, E, Huynh-Le, M, Hwang, C, Jani, C, Jayaraj, A, Johnson, DB, Kasi, A, Khan, H, Koshkin, VS, Kuderer, NM, Kwon, DH, Lammers, PE, Li, A, Loaiza-Bonilla, A, Low, CA, Lustberg, MB, Lyman, GH, McKay, RR, McNair, C, Menon, H, Mesa, RA, Mico, V, Mundt, D, Nagaraj, G, Nakasone, ES, Nakayama, J, Nizam, A, Nock, NL, Park, C, Patel, JM, Patel, KG, Peddi, P, Pennell, NA, Piper-Vallillo, AJ, Puc, M, Ravindranathan, D, Reeves, ME, Reuben, DY, Rosenstein, L, Rosovsky, RP, Rubinstein, SM, Salazar, M, Schmidt, AL, Schwartz, GK

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology, vol 32, iss 6

BackgroundPatients with cancer may be at high risk of adverse outcomes from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We analyzed a cohort of patients with cancer and coronavirus 2019 (COVID-19) reported to the COVID-19

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::32464797f1049465c364360d3ca626d5
https://escholarship.org/uc/item/49m429m0

Evaluating the utility of ZNF331 promoter methylation as a prognostic and predictive marker in stage III colon cancer: results from CALGB 89803 (Alliance).

Autor: Nakasone ES; Division of Oncology, University of Washington, Seattle, WA, USA.; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Zemla TJ; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN, USA., Yu M; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Lin SY; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; School of Life Sciences, Nantong University, Nantong, P.R. China., Ou FS; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN, USA., Carter K; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Innocenti F; Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Saltz L; Department of Gastrointestinal Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Grady WM; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Division of Gastroenterology, University of Washington, Seattle, WA, USA., Cohen SA; Division of Oncology, University of Washington, Seattle, WA, USA.; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.

Publikováno v: Epigenetics [Epigenetics] 2024 Dec; Vol. 19 (1), pp. 2349980. Date of Electronic Publication: 2024 May 08.

Platelet and HIV Interactions and Their Contribution to Non-AIDS Comorbidities.

Autor: Awamura T; Department of Tropical Medicine, Medical Microbiology, and Pharmacology, John A. Burns School Medicine, University of Hawai'i at Mānoa, Honolulu, HI 96813, USA., Nakasone ES; University of Hawai'i Cancer Center, University of Hawai'i at Mānoa, Honolulu, HI 96813, USA.; Department of Medicine, John A. Burns School of Medicine, University of Hawai'i at Mānoa, Honolulu, HI 96813, USA., Gangcuangco LM; Hawai'i Center for AIDS, John A. Burns School of Medicine, University of Hawai'i at Mānoa, Honolulu, HI 96813, USA., Subia NT; Department of Tropical Medicine, Medical Microbiology, and Pharmacology, John A. Burns School Medicine, University of Hawai'i at Mānoa, Honolulu, HI 96813, USA., Bali AJ; Department of Tropical Medicine, Medical Microbiology, and Pharmacology, John A. Burns School Medicine, University of Hawai'i at Mānoa, Honolulu, HI 96813, USA., Chow DC; Department of Medicine, John A. Burns School of Medicine, University of Hawai'i at Mānoa, Honolulu, HI 96813, USA.; Hawai'i Center for AIDS, John A. Burns School of Medicine, University of Hawai'i at Mānoa, Honolulu, HI 96813, USA., Shikuma CM; Hawai'i Center for AIDS, John A. Burns School of Medicine, University of Hawai'i at Mānoa, Honolulu, HI 96813, USA., Park J; Department of Tropical Medicine, Medical Microbiology, and Pharmacology, John A. Burns School Medicine, University of Hawai'i at Mānoa, Honolulu, HI 96813, USA.; Hawai'i Center for AIDS, John A. Burns School of Medicine, University of Hawai'i at Mānoa, Honolulu, HI 96813, USA.

Publikováno v: Biomolecules [Biomolecules] 2023 Nov 02; Vol. 13 (11). Date of Electronic Publication: 2023 Nov 02.

Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort Study.

Autor: Wagner MJ; Department of Medicine, University of Washington, and Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Hennessy C; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN 37232, USA., Beeghly A; Department of Medicine, Division of Epidemiology, Vanderbilt University Medical Center, Nashville, TN 37232, USA., French B; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN 37232, USA., Shah DP; Department of Population Health Sciences, UT Health San Antonio, San Antonio, TX 78229, USA., Croessmann S; Department of Medicine, Division of Hematology and Oncology, Vanderbilt University, Nashville, TN 37232, USA., Vilar-Compte D; Department of Infectious Diseases, Instituto Nacional de Cancerología, Mexico City 14080, Mexico., Ruiz-Garcia E; Department of Infectious Diseases, Instituto Nacional de Cancerología, Mexico City 14080, Mexico., Ingham M; Department of Medicine, Columbia University Irving Medical Center, New York, NY 10032, USA., Schwartz GK; Department of Medicine, Columbia University Irving Medical Center, New York, NY 10032, USA., Painter CA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Chugh R; Department of Hematology and Oncology, University of Michigan, Ann Arbor, MI 48109, USA., Fecher L; Department of Hematology and Oncology, University of Michigan, Ann Arbor, MI 48109, USA., Park C; University of Cincinnati Cancer Center, Cincinnati, OH 45267, USA., Zamulko O; University of Cincinnati Cancer Center, Cincinnati, OH 45267, USA., Trent JC; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL 33136, USA., Subbiah V; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Khaki AR; Department of Medicine, Stanford University, Stanford, CA 94304, USA., Tachiki L; Department of Medicine, University of Washington, and Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Nakasone ES; Department of Medicine, University of Washington, and Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Loggers ET; Department of Medicine, University of Washington, and Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Labaki C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Saliby RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., McKay RR; Department of Medicine, Moores Cancer Center, University of California San Diego, San Diego, CA 92037, USA., Ajmera A; Department of Medicine, Moores Cancer Center, University of California San Diego, San Diego, CA 92037, USA., Griffiths EA; Department of Medicine, Roswell Park Comprehensive Cancer Center, University of Buffalo, Buffalo, NY 14203, USA., Puzanov I; Department of Medicine, Roswell Park Comprehensive Cancer Center, University of Buffalo, Buffalo, NY 14203, USA., Tap WD; Department of Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA., Hwang C; Henry Ford Cancer Institute, Detroit, MI 48202, USA., Tejwani S; Henry Ford Cancer Institute, Detroit, MI 48202, USA., Jhawar SR; Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA., Hayes-Lattin B; Division of Hematology and Medical Oncology, Knight Cancer Institute at Oregon Health and Science University, Portland, OR 97239, USA., Wulff-Burchfield E; Department of Medicine, The University of Kansas Medical Center, Kansas City, KS 66103, USA., Kasi A; Department of Medicine, The University of Kansas Medical Center, Kansas City, KS 66103, USA., Reuben DY; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA., Nagaraj G; Division of Hematology and Oncology, Loma Linda University School of Medicine, California, CA 92354, USA., Joshi M; Department of Medicine, Division of Hematology-Oncology, Penn State Cancer Institute, Hershey, PA 17033, USA., Polimera H; Department of Medicine, Division of Hematology-Oncology, Penn State Cancer Institute, Hershey, PA 17033, USA., Kulkarni AA; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA., Esfahani K; Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, QC H4A 3J1, Canada., Kwon DH; UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, California, CA 94117, USA., Paoluzzi L; Department of Oncology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY 10467, USA., Bilen MA; Department of Oncology, Emory University, Atlanta, GA 30322, USA., Durbin EB; Division of Biomedical Informatics, College of Medicine, University of Kentucky, Lexington, KY 40536, USA., Grivas P; Department of Medicine, University of Washington, and Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Warner JL; Department of Medicine, Division of Hematology and Oncology, Vanderbilt University, Nashville, TN 37232, USA.; Department of Biomedical Informatics, Vanderbilt University, Nashville, TN 37232, USA., Davis EJ; Department of Medicine, Division of Hematology and Oncology, Vanderbilt University, Nashville, TN 37232, USA.

Publikováno v: Cancers [Cancers (Basel)] 2022 Sep 05; Vol. 14 (17). Date of Electronic Publication: 2022 Sep 05.

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium.

Autor: Grivas P; University of Washington/Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, USA. Electronic address: pgrivas@uw.edu., Khaki AR; University of Washington/Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, USA; Stanford University, Stanford, USA., Wise-Draper TM; University of Cincinnati Cancer Center, Cincinnati, USA., French B; Vanderbilt University Medical Center, Nashville, USA., Hennessy C; Vanderbilt University Medical Center, Nashville, USA., Hsu CY; Vanderbilt University Medical Center, Nashville, USA., Shyr Y; Vanderbilt University Medical Center, Nashville, USA., Li X; Vanderbilt University School of Medicine, Nashville, USA., Choueiri TK; Dana-Farber Cancer Institute, Boston, USA., Painter CA; Broad Institute, Cancer Program, Cambridge, USA., Peters S; Lausanne University, Lausanne, Switzerland., Rini BI; Vanderbilt University Medical Center, Nashville, USA., Thompson MA; Advocate Aurora Health, Milwaukee, USA., Mishra S; Vanderbilt University Medical Center, Nashville, USA., Rivera DR; Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, USA., Acoba JD; University of Hawaii Cancer Center, Honolulu, USA., Abidi MZ; University of Colorado School of Medicine, Aurora, USA., Bakouny Z; Dana-Farber Cancer Institute, Boston, USA., Bashir B; Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, USA., Bekaii-Saab T; Mayo Clinic Cancer Center, Phoenix, USA., Berg S; Cardinal Bernardin Cancer Center, Loyola University Medical Center, Maywood, USA., Bernicker EH; Houston Methodist Cancer Center, Houston, USA., Bilen MA; Winship Cancer Institute of Emory University, Atlanta, USA., Bindal P; Beth Israel Deaconess Medical Center, Boston, USA., Bishnoi R; University of Florida, Gainesville, USA., Bouganim N; McGill University Health Centre, Montréal, Canada., Bowles DW; University of Colorado School of Medicine, Aurora, USA., Cabal A; University of California San Diego, Moores Cancer Center, La Jolla, USA., Caimi PF; University Hospitals Seidman Cancer Center, Cleveland, USA; Case Western Reserve University, Cleveland, USA., Chism DD; Thompson Cancer Survival Center, Knoxville, USA., Crowell J; St. Elizabeth Healthcare, Edgewood, USA., Curran C; Dana-Farber Cancer Institute, Boston, USA., Desai A; Mayo Clinic Cancer Center, Rochester, USA., Dixon B; St. Elizabeth Healthcare, Edgewood, USA., Doroshow DB; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA., Durbin EB; Markey Cancer Center, University of Kentucky, Lexington, USA., Elkrief A; McGill University Health Centre, Montréal, Canada., Farmakiotis D; The Warren Alpert Medical School of Brown University, Providence, USA., Fazio A; Tufts Medical Center Cancer Center, Boston and Stoneham, USA., Fecher LA; University of Michigan Rogel Cancer Center, Ann Arbor, USA., Flora DB; St. Elizabeth Healthcare, Edgewood, USA., Friese CR; University of Michigan Rogel Cancer Center, Ann Arbor, USA., Fu J; Tufts Medical Center Cancer Center, Boston and Stoneham, USA., Gadgeel SM; Henry Ford Cancer Institute/Henry Ford Health System, Detroit, USA., Galsky MD; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA., Gill DM; Intermountain Healthcare, Salt Lake City, USA., Glover MJ; Stanford University, Stanford, USA., Goyal S; George Washington University, Washington DC, USA., Grover P; University of Cincinnati Cancer Center, Cincinnati, USA., Gulati S; University of Cincinnati Cancer Center, Cincinnati, USA., Gupta S; Cleveland Clinic Taussig Cancer Institute, Cleveland, USA., Halabi S; Duke University, Durham, USA., Halfdanarson TR; Mayo Clinic Cancer Center, Rochester, USA., Halmos B; Albert Einstein Cancer Center/Montefiore Medical Center, Bronx, USA., Hausrath DJ; Vanderbilt University School of Medicine, Nashville, USA., Hawley JE; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, USA., Hsu E; Hartford HealthCare, Hartford, USA; University of Connecticut, Farmington, USA., Huynh-Le M; George Washington University, Washington DC, USA., Hwang C; Henry Ford Cancer Institute/Henry Ford Health System, Detroit, USA., Jani C; Mount Auburn Hospital, Cambridge, USA., Jayaraj A; Hartford HealthCare, Hartford, USA., Johnson DB; Vanderbilt University Medical Center, Nashville, USA., Kasi A; University of Kansas Medical Center, Kansas City, USA., Khan H; The Warren Alpert Medical School of Brown University, Providence, USA., Koshkin VS; University of California, San Francisco, San Francisco, USA., Kuderer NM; Advanced Cancer Research Group, LLC, Kirkland, USA., Kwon DH; University of California, San Francisco, San Francisco, USA., Lammers PE; Baptist Cancer Center, Memphis, USA., Li A; Baylor College of Medicine, Houston, USA., Loaiza-Bonilla A; Cancer Treatment Centers of America, Philadelphia, USA., Low CA; Intermountain Healthcare, Salt Lake City, USA., Lustberg MB; The Ohio State University, Columbus, USA., Lyman GH; University of Washington/Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, USA., McKay RR; University of California San Diego, Moores Cancer Center, La Jolla, USA., McNair C; Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, USA., Menon H; Penn State Health/Penn State Cancer Institute/St. Joseph Cancer Center, Hershey, USA., Mesa RA; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, USA., Mico V; Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, USA., Mundt D; Advocate Aurora Health, Milwaukee, USA., Nagaraj G; Loma Linda University Cancer Center, Loma Linda, USA., Nakasone ES; University of Washington/Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, USA., Nakayama J; Case Western Reserve University, Cleveland, USA; University Hospitals Cleveland Medical Center, Cleveland, USA., Nizam A; Cleveland Clinic Taussig Cancer Institute, Cleveland, USA., Nock NL; University Hospitals Seidman Cancer Center, Cleveland, USA; Case Western Reserve University, Cleveland, USA., Park C; University of Cincinnati Cancer Center, Cincinnati, USA., Patel JM; Beth Israel Deaconess Medical Center, Boston, USA., Patel KG; University of California Davis Comprehensive Cancer Center, Sacramento, USA., Peddi P; Willis-Knighton Cancer Center, Shreveport, USA., Pennell NA; Cleveland Clinic Taussig Cancer Institute, Cleveland, USA., Piper-Vallillo AJ; Beth Israel Deaconess Medical Center, Boston, USA., Puc M; Virtua Health, Marlton, USA., Ravindranathan D; Winship Cancer Institute of Emory University, Atlanta, USA., Reeves ME; Loma Linda University Cancer Center, Loma Linda, USA., Reuben DY; Medical University of South Carolina, Charleston, USA., Rosenstein L; Gunderson Health System, La Crosse, USA., Rosovsky RP; Massachusetts General Hospital, Harvard Medical School, Boston, USA., Rubinstein SM; University of North Carolina, Chapel Hill, USA., Salazar M; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, USA., Schmidt AL; Dana-Farber Cancer Institute, Boston, USA., Schwartz GK; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, USA., Shah MR; Rutgers Cancer Institute of New Jersey, New Brunswick, USA., Shah SA; Stanford University, Stanford, USA., Shah C; University of Florida, Gainesville, USA., Shaya JA; University of California San Diego, Moores Cancer Center, La Jolla, USA., Singh SRK; Henry Ford Cancer Institute/Henry Ford Health System, Detroit, USA., Smits M; ThedaCare Regional Cancer Center, Appleton, USA., Stockerl-Goldstein KE; Siteman Cancer Center, Washington University School of Medicine, St. Louis, USA., Stover DG; The Ohio State University, Columbus, USA., Streckfuss M; Advocate Aurora Health, Milwaukee, USA., Subbiah S; Stanley S. Scott Cancer Center, LSU Health Sciences Center, New Orleans, USA., Tachiki L; University of Washington/Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, USA., Tadesse E; Advocate Aurora Health, Milwaukee, USA., Thakkar A; Albert Einstein Cancer Center/Montefiore Medical Center, Bronx, USA., Tucker MD; Vanderbilt University Medical Center, Nashville, USA., Verma AK; Albert Einstein Cancer Center/Montefiore Medical Center, Bronx, USA., Vinh DC; McGill University Health Centre, Montréal, Canada., Weiss M; ThedaCare Regional Cancer Center, Appleton, USA., Wu JT; Stanford University, Stanford, USA., Wulff-Burchfield E; Mount Auburn Hospital, Cambridge, USA., Xie Z; Mayo Clinic Cancer Center, Rochester, USA., Yu PP; Hartford HealthCare, Hartford, USA., Zhang T; Duke University, Durham, USA., Zhou AY; Siteman Cancer Center, Washington University School of Medicine, St. Louis, USA., Zhu H; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, USA., Zubiri L; Massachusetts General Hospital, Harvard Medical School, Boston, USA., Shah DP; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, USA., Warner JL; Vanderbilt University Medical Center, Nashville, USA., Lopes G; University of Miami/Sylvester Comprehensive Cancer Center, Miami, USA.

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2021 Jun; Vol. 32 (6), pp. 787-800. Date of Electronic Publication: 2021 Mar 19.